2024 Multidisciplinary Head and Neck Cancers Symposium Credit Evaluation

February 29, 2024 to March 2, 2024

The 2024 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day meeting featuring interactive and case-based educational sessions that cover new multidisciplinary therapies, imaging, immunotherapy, treatment guidelines, supportive care and understanding disparities in head and neck cancer. A major focus is placed on the multidisciplinary nature of disease management and the incorporation of all treatment modalities to achieve best outcomes. Oral abstract and poster sessions will highlight cutting-edge science and evidence-based practice. Attendees will be able to examine multidisciplinary approaches for treating head and neck cancer, as well as novel therapies that show promise in improving outcomes.

 

Target Audience

This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language pathologists/scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, scientists, immunologist and rehabilitation specialists.

Learning Objectives

Upon completion of this live activity, participants should be able to:

 

  • Explain the importance of multidisciplinary care in HNC and how to best apply it for optimal outcomes.
  • Describe key advances in systemic therapy, including targeted therapy and immunotherapy in HNC.
  • Discuss recent advances in minimally invasive surgery in HNC and when to apply it in treating early and locally advanced disease.
  • Illustrate how we can improve disparities in HNC care.
  • Determine the importance of interventions in survivorship clinics for long-term side effects.
  • Describe key advances in radiation therapy delivery, targeting and differences between various modalities, including novel treatment approaches such as proton and FLASH radiotherapy.
  • Discuss complex cases in HNC and how to best utilize current knowledge for decision making.
  • Manage toxicities related to the management of HNC.
  • Summarize key recent advances in HNC biology.
  • Summarize key recent advances in HNC imaging.
  • Discuss and implement standard treatment guidelines for various subtypes of HNCs.
Course summary
Available credit: 
  • 18.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 18.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 18.25 Certificate of Attendance
    This activity was designated for 18.25 AMA PRA Category 1 Credit™.
  • 16.49 CAMPEP
    This activity has been approved for 16.49 medical physics continuing education credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).
Course opens: 
01/30/2024
Course expires: 
04/01/2024
Event starts: 
02/29/2024 - 6:00am EST
Event ends: 
03/02/2024 - 12:00pm EST
Cost:
$0.00
Rating: 
0

Faculty:
A list of all meeting faculty and Individual presenter disclosures are linked to their names in the Schedule of Events.

Planning Committee:
A list of all meeting planning committee members and their individual disclosures can be found on the Planning Committee webpage.

Physicians
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

ASTRO designates this live activity for a maximum of 18 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME certificates of credit are only available to participants who have completed the online evaluation tool. Participants can access, print and save their certificate from the ASTRO Academy.

Physicists
This activity has been approved for a maximum of 16.49 Medical Physics Continuing Education Credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Program (CAMPEP).

Physicist attendees will receive a confirmation certificate of credit from ASTRO. The names of physicist attendees will be sent to CAMPEP 45 days after the meeting. Your official certificate will be available from CAMPEP.

 

Available Credit

  • 18.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 18.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 18.25 Certificate of Attendance
    This activity was designated for 18.25 AMA PRA Category 1 Credit™.
  • 16.49 CAMPEP
    This activity has been approved for 16.49 medical physics continuing education credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).

Price

Cost:
$0.00
Please login or register to take this course.

To be eligible to receive continuing education credit, attendees must complete the online evaluation by Monday, April 1, 2024. Please only evaluate the sessions you attended.

CME certificates of credit are only available to participants who have completed the online evaluation tool. Participants will have online access to their certificate upon completion of the evaluation. Participants can access, print and save their certificate from ASTRO Academy.

Physicist attendees will not receive certificates of credit from ASTRO. The names of physicist attendees will be sent to CAMPEP 45 days after the meeting.